[

covishield

]
PAGE 3

Delta variant: No antibodies in 16% after second dose of Covishield, says study

The titres of the neutralising antibodies – that specifically target the Sars-CoV-2 virus and kill it or prevent it from entering human cells – were also lower against the Delta variant as compared to the B1 variant that led to the first wave of infections in India.
After two doses, the neutralising antibodies could not be detected in 16.1% of the samples, the study found. (Bloomberg)
After two doses, the neutralising antibodies could not be detected in 16.1% of the samples, the study found. (Bloomberg)
Updated on Jul 04, 2021 03:30 AM IST
Copy Link
By Anonna Dutt, New Delhi, Hindustan Times

Who are 'highly protected' against Delta variant of Covid? ICMR study reveals

Covid recovered with even one dose of the vaccine have higher protection against Delta variant than those who have never been infected but have got vaccinated.
The study only evaluated the immune response of the Covishield vaccine among various groups of partially and fully vaccinated people. (Bloomberg)
The study only evaluated the immune response of the Covishield vaccine among various groups of partially and fully vaccinated people. (Bloomberg)
Published on Jul 03, 2021 10:51 PM IST
Copy Link
By hindustantimes.com | Written by Poulomi Ghosh

'Treat vaccinated Indians on par with those inoculated in EU states': India

  • The remarks by external affairs ministry spokesperson Arindam Bagchi came at a weekly news briefing on Friday.
A healthcare worker fills a syringe with a dose of Covid-19 vaccine.(REUTERS)
A healthcare worker fills a syringe with a dose of Covid-19 vaccine.(REUTERS)
Updated on Jul 02, 2021 09:20 PM IST
Copy Link
By Rezaul H Laskar, New Delhi

Can Indians now travel to European countries? All you need to know

The Embassy of Switzerland has recently lifted travel restrictions and Indians fully vaccinated with Covishield can travel to Switzerland, but the country does not approve Covaxin.
European countries are yet to lift travel restrictions for Indians.(Vipin Kumar/HT Photo)
European countries are yet to lift travel restrictions for Indians.(Vipin Kumar/HT Photo)
Published on Jul 01, 2021 12:54 PM IST
Copy Link
By hindustantimes.com | Written by Poulomi Ghosh

'No controversy': Adar Poonawalla on Covishield being excluded from EU pass

Adar Poonwalla said Covishield will receive approval from the European Medicines Agency in a month.
Covishield will receive EMA approval in a month and nothing will be hindered, Serum Institute CEO Adar Poonawalla has said. (REUTERS)
Covishield will receive EMA approval in a month and nothing will be hindered, Serum Institute CEO Adar Poonawalla has said. (REUTERS)
Published on Jul 01, 2021 11:24 AM IST
Copy Link
By hindustantimes.com | Written by Poulomi Ghosh

SII produces 90 million doses a month, says CEO amid reports of vaccine shortage

Covid-19 vaccine shortage in India: Several states and Union territories, including Odisha, Punjab, and Delhi, have flagged a shortage of Covid-19 vaccines earlier this week amid the inoculation drive.
Covishield vaccine vials during a vaccination drive, at Navyug School, Mandir Marg, in New Delhi, India, on Tuesday, June 29, 2021. (Photo by Sanchit Khanna/ Hindustan Times)
Covishield vaccine vials during a vaccination drive, at Navyug School, Mandir Marg, in New Delhi, India, on Tuesday, June 29, 2021. (Photo by Sanchit Khanna/ Hindustan Times)
Published on Jul 01, 2021 06:23 AM IST
Copy Link
By hindustantimes.com | Written by Joydeep Bose

Green Pass: Jaishankar discusses Covishield with top EU official

From July 1, a 'Green Pass' will be needed to travel freely within the European Union (EU). Covishield is not among the four vaccines cleared by the European Medicines Agency (EMA).
S Jaishankar with EU official Josep Borrell Fontelles (twitter.com/DrSJaishankar)
S Jaishankar with EU official Josep Borrell Fontelles (twitter.com/DrSJaishankar)
Updated on Jun 30, 2021 08:44 AM IST
Copy Link
By hindustantimes.com | Written by Karan Manral | Edited by Amit Chaturvedi, New Delhi

No Covid vaccination at government centres in Noida on June 30

  • The decision to cancel all vaccinations, including Covishield and Covaxin, has been taken due to "unavoidable" reasons, Chief Medical Officer Dr. Deepak Ohri said.
The order does not apply to private facilities. (Photo by Sunil Ghosh / Hindustan Times)
The order does not apply to private facilities. (Photo by Sunil Ghosh / Hindustan Times)
Published on Jun 29, 2021 10:35 PM IST
Copy Link
PTI | , Noida

EMA had not received Covishield approval request for 'Green Pass': EU

  • The official clarified that the EU Digital COVID Certificate is meant to facilitate restriction-free movement with the member states and is not a pre-condition to travel.
Those vaccinated with Covishield may not be eligible for the EU ‘Green Pass’ that will be available to use from July 1.(AFP)
Those vaccinated with Covishield may not be eligible for the EU ‘Green Pass’ that will be available to use from July 1.(AFP)
Updated on Jun 29, 2021 03:26 PM IST
Copy Link
By hindustantimes.com | Edited by Kunal Gaurav, Hindustan Times, New Delhi

EU’s ‘green pass’ for Covishield: What is the document all about

The Serum Institute of India is approaching the European Medicines Agency for approval of its Covid-19 vaccine, Covishield, for the European Union’s Green Pass.
The Serum Institute of India is approaching the EMA for approval of its Covid-19 vaccine, Covishield, for the European Union’s Green Pass. (File Photo)
The Serum Institute of India is approaching the EMA for approval of its Covid-19 vaccine, Covishield, for the European Union’s Green Pass. (File Photo)
Published on Jun 29, 2021 05:28 AM IST
Copy Link
By hindustantimes.com | Written by Meenakshi Ray, New Delhi

SII says working on Covishield EU pass

Indian officials said it was “perplexing” that the list includes Vaxzevria, the AstraZeneca vaccine produced and marketed in the UK and other sites around Europe, but not Covishield, the version manufactured and distributed in India, though they are similar if not identical.
The Covishield vaccine “does not currently have a marketing authorisation” in Europe and the matter would be considered when an application is received for it, the EMA said.(AFP )
The Covishield vaccine “does not currently have a marketing authorisation” in Europe and the matter would be considered when an application is received for it, the EMA said.(AFP )
Updated on Jun 29, 2021 04:41 AM IST
Copy Link
By HT Correspondent, Hindustan Times, New Delhi

Soni reacts to Covishield’s exclusion from EU’s Green Pass eligibility list

Soni Razdan is unhappy about Covishield, a version of the AstraZeneca Covid-19 vaccine manufactured by Serum Institute of India and approved by WHO, being excluded from the eligibility list for the EU’s Green Pass.
Soni Razdan is unhappy about Covishield being excluded from the eligibility list for the EU’s Green Pass.
Soni Razdan is unhappy about Covishield being excluded from the eligibility list for the EU’s Green Pass.
Published on Jun 28, 2021 09:53 AM IST
Copy Link

Covishield may not be eligible for ‘vaccine passport’ by the EU

The European Union had earlier said that member states can issue the certificates regardless of the type of Covid-19 vaccine, but the technical specifications indicate that the pass will be limited to “vaccines that have received EU-wide marketing authorization”.
A majority of people in India have received Covishield, manufactured locally by Pune-based Serum Institute of India.(Vipin Kumar /HT file photo)
A majority of people in India have received Covishield, manufactured locally by Pune-based Serum Institute of India.(Vipin Kumar /HT file photo)
Updated on Jun 28, 2021 05:48 AM IST
Copy Link
By HT Correspondent, Hindustan Times, New Delhi

Covishield excluded from new EU Covid 'Green Pass' eligibility list

  • Covishield, a version of the AstraZeneca Covid vaccine manufactured by Pune-based Serum Institute of India (SII), has not been approved by the EMA for the European market.
Covishield, a version of the AstraZeneca Covid vaccine, has not been approved by the EMA for the European market.(AP)
Covishield, a version of the AstraZeneca Covid vaccine, has not been approved by the EMA for the European market.(AP)
Published on Jun 27, 2021 07:53 PM IST
Copy Link
By hindustantimes.com | Edited by Kunal Gaurav, Hindustan Times, New Delhi

Covid-19: How will you be compensated if things go south after vaccination?

Serum Institute of India's (SII) Covishield, Bharat Biotech’s Covaxin and Russia’s Sputnik V are the three vaccines which have been cleared by the Indian government.
As many as 32,17,60,077 people have been vaccinated against Covid-19 in India as of now.(HT file photo)
As many as 32,17,60,077 people have been vaccinated against Covid-19 in India as of now.(HT file photo)
Published on Jun 27, 2021 10:49 AM IST
Copy Link
Written by Prashasti Singh | Edited by Meenakshi Ray, Hindustan Times, New Delhi

India administered over six million Covid-19 vaccine doses in a day

Daily recoveries continue to outnumber the single-day spike for the 43rd consecutive day, the central government said. The recovery rate has increased to 96.66% while the weekly positivity rate remains below 5% and is currently at 3%.
A health worker prepares a dose of the Covishield vaccine, developed by Oxford-AstraZeneca Plc. and manufactured by Serum Institute of India Ltd., for a student, who has a place to study abroad, at a Covid-19 vaccination center set up in a school in New Delhi India, on Thursday, June 24, 2021. (Bloomberg)
A health worker prepares a dose of the Covishield vaccine, developed by Oxford-AstraZeneca Plc. and manufactured by Serum Institute of India Ltd., for a student, who has a place to study abroad, at a Covid-19 vaccination center set up in a school in New Delhi India, on Thursday, June 24, 2021. (Bloomberg)
Published on Jun 25, 2021 10:01 AM IST
Copy Link
By hindustantimes.com | Edited by Joydeep Bose

Vaccines administered did not contain anything harmful: Mimi Chakraborty

  • Mimi Chakraborty was invited to the vaccination camp on Wednesday by a man who claimed it was meant for inoculating transgender individuals and the disabled
Trinamool Congress MP Mimi Chakraborty got herself vaccinated with Covishield in a bid to encourage others to do the same but grew suspicious when she did not receive a vaccination certificate. (LSTV/PTI Photo)
Trinamool Congress MP Mimi Chakraborty got herself vaccinated with Covishield in a bid to encourage others to do the same but grew suspicious when she did not receive a vaccination certificate. (LSTV/PTI Photo)
Updated on Jun 24, 2021 08:18 PM IST
Copy Link
By hindustantimes.com | Edited by Ayshee Bhaduri, Hindustan Times, New Delhi

Delhi vaccinating citizens regularly unlike Madhya Pradesh: AAP slams Centre

  • “We are not vaccinating like Madhya Pradesh, inoculating lakhs in a day and unable to vaccinate even 1,000 on other days. We are not vaccinating for photo-ops or event management,” said Satyendar Jain
Delhi health minister Satyendar Jain’s reaction followed Union minister Hardeep Singh Puri’s criticism of the Arvind Kejriwal-led Delhi government’s vaccination drive.
Delhi health minister Satyendar Jain’s reaction followed Union minister Hardeep Singh Puri’s criticism of the Arvind Kejriwal-led Delhi government’s vaccination drive.
Updated on Jun 23, 2021 04:45 PM IST
Copy Link
By hindustantimes.com, Hindustan Times, New Delhi

Free vaccination for all from today as new policy rolls out

  • The aim of the government is to vaccinate all adults in the country against Covid-19 by the end of this year
To vaccinate adults in the remaining population group of 18-45 years category, state governments and private hospitals and institutions were free to procure directly from the manufacturer from the remaining 50% supplies.(PTI)
To vaccinate adults in the remaining population group of 18-45 years category, state governments and private hospitals and institutions were free to procure directly from the manufacturer from the remaining 50% supplies.(PTI)
Updated on Jun 21, 2021 01:06 AM IST
Copy Link
By Rhythma Kaul, New Delhi

Plan for walk-in jabs for 18-45 group in the works: Delhi government

  • On Saturday, 85,907 people were vaccinated in Delhi, out of which 52,060 were from the 18-45 year age category.
For the 18-45 age group, 268,000 vaccine doses are available, which translates to a day’s stock of Covaxin and 13 days stock of Covishield.
For the 18-45 age group, 268,000 vaccine doses are available, which translates to a day’s stock of Covaxin and 13 days stock of Covishield.
Updated on Jun 21, 2021 05:08 AM IST
Copy Link
By HT Correspondent and PTI, New Delhi

67-yr-old woman administered two jabs of different vaccines in Bihar

  • On June 16, Sunila Devi was administered shots of the two vaccines in a space of five minutes at the Utkramit Vidyalaya, a rural camp in Patna district’s Beldarichak village.
After five minutes, another ANM, giving shots to the 18-45 years age group, administered her a dose of Covishield to Sunila Devi,
After five minutes, another ANM, giving shots to the 18-45 years age group, administered her a dose of Covishield to Sunila Devi,
Published on Jun 20, 2021 03:53 AM IST
Copy Link
By Ruchir Kumar, Patna

295k doses available for 18-44 age group: Atishi

  • Presenting the Delhi government’s daily vaccination bulletin, the MLA from Kalkaji said Delhi now has 258,000 doses of Covishield and 37,000 doses of Covaxin available for the 18-44 age group.
"Here, we are happy to share that Delhi on Friday received 167,000 Covishield doses for the 18-44 age group,” said Atishi.(Screengrab)
Published on Jun 20, 2021 02:48 AM IST
Copy Link
By HT Correspondent, New Delhi

Covishield: Second dose in 3 months? Here's what AstraZeneca trial chief says

The goal of the immunisation policy in India, said Professor Andrew Pollard, is to ensure at least one dose of the Covid-19 vaccine for the largest number of people at the earliest, which is understandable with regards to the present coronavirus disease (Covid-19) situation in the country.
A health worker prepares to inoculate a beneficiary with a dose of the Covishield vaccine against the Covid-19 coronavirus, during a vaccine drive organized by the non-governmental organization (NGO) 'Anubhav' in Siliguri on June 17, 2021. (Photo by Diptendu DUTTA / AFP)
A health worker prepares to inoculate a beneficiary with a dose of the Covishield vaccine against the Covid-19 coronavirus, during a vaccine drive organized by the non-governmental organization (NGO) 'Anubhav' in Siliguri on June 17, 2021. (Photo by Diptendu DUTTA / AFP)
Published on Jun 19, 2021 07:19 AM IST
Copy Link
By hindustantimes.com | Written by Joydeep Bose

India concerned over lack of uniform vaccination requirements across world

  • The US embassy began scheduling visa interviews for Indian students this week and American officials have said applicants won’t require proof of Covid-19 vaccination to enter the US.
Covaxin and Covishield are the two main jabs being used in India’s vaccination programme(Sanchit Khanna/HT PHOTO)
Covaxin and Covishield are the two main jabs being used in India’s vaccination programme(Sanchit Khanna/HT PHOTO)
Updated on Jun 18, 2021 05:06 AM IST
Copy Link
By Rezaul H Laskar, New Delhi

Covishield vaccinated Indians not required to quarantine in South Korea: Envoy

  • South Korea: Those who are vaccinated with Covaxin will have to follow quarantine guidelines for two weeks, unlike the ones who have received Covishield.
Pedestrians walk past a poster depicting the coronavirus, at the City Hall in Seoul, South Korea.(AFP for representation)
Pedestrians walk past a poster depicting the coronavirus, at the City Hall in Seoul, South Korea.(AFP for representation)
Published on Jun 16, 2021 10:38 PM IST
Copy Link
By hindustantimes.com | Written by Deepali Sharma | Edited by Avik Roy, Hindustan Times, New Delhi

'Even Aryabhatta, Aristotle...': Harsh Vardhan's Covishield jibe at Rahul Gandhi

Experts who reportedly said the decision to increase the gap between the two doses of Covishield vaccines was not unanimous were present at the meeting and agreed to the decision, the government said on Wednesday and released proof.
Dr Harsh Vardhan on Wednesday mocked at Rahul Gandhi for questioning the decision of delaying Covishield 2nd dose by three months.
Dr Harsh Vardhan on Wednesday mocked at Rahul Gandhi for questioning the decision of delaying Covishield 2nd dose by three months.
Updated on Jun 16, 2021 06:49 PM IST
Copy Link
By hindustantimes.com | Edited by Poulomi Ghosh

Rahul Gandhi hits out at Centre over 'prolonged' gap between Covishield doses

Rahul Gandhi, who has been the most vocal critic of the Centre’s response to the pandemic, has time and again criticised it over its vaccination policy. On May 28, he said vaccination is the only permanent solution to combat Covid-19 and only a minuscule percentage of the country’s population was inoculated.
GOI’s constant attempts to save the PM's fake image are facilitating the virus and costing people’s lives, Rahul Gandhi said. (File photo)
GOI’s constant attempts to save the PM's fake image are facilitating the virus and costing people’s lives, Rahul Gandhi said. (File photo)
Published on Jun 16, 2021 04:10 PM IST
Copy Link
By hindustantimes.com | Written by Harshit Sabarwal | Edited by Avik Roy, New Delhi

Covishield: Govt says extending gap to 12-16 weeks was a unanimous decision

Covishield: Increasing the gap between the two doses of Covishield to 12 to 16 weeks was what all experts agreed to, the government has said after reports of dissent surfaces.
Covishield doses are now being administered at an interval of 12 to 16 weeks. (Vipin Kumar /HT PHOTO)
Covishield doses are now being administered at an interval of 12 to 16 weeks. (Vipin Kumar /HT PHOTO)
Published on Jun 16, 2021 09:51 AM IST
Copy Link
By hindustantimes.com | Edited by Poulomi Ghosh

Half of govt vaccination centres for 18+ group shut, says AAP MLA Atishi

In the government’s vaccination bulletin issued online on Tuesday, Atishi said the position is “quite comfortable” for people aged 45 and above, and over 50% eligible people in this group have been vaccinated.
AAP leader Atishi Marlena(Screengrab)
AAP leader Atishi Marlena(Screengrab)
Updated on Jun 16, 2021 05:15 AM IST
Copy Link
By HT Correspondent, Hindustan Times, New Delhi

Didn't back increased interval between Covid-19 vaccine doses: NTAGI scientists

  • Announcing the decision to increase the gap between the two Covid-19 vaccine doses from six to eight weeks to 12-16 weeks, the government said it was recommended by NTAGI, based on real-life evidence mainly from the United Kingdom.
The government's decision to increase the interval between the doses came at a time when the country was facing a huge paucity of Covid-19 vaccine doses.
The government's decision to increase the interval between the doses came at a time when the country was facing a huge paucity of Covid-19 vaccine doses.
Published on Jun 15, 2021 10:47 PM IST
Copy Link
By hindustantimes.com | Written by Deepali Sharma | Edited by Avik Roy, Hindustan Times, New Delhi
SHARE
  • 1
  • 2
  • 3
  • ...
Story Saved
×
Saved Articles
My Reads
Sign out
New Delhi 0C
Monday, October 18, 2021